Lung disease may be the fourth leading cause of death in the United States, but it receives hundreds of millions of dollars less in research funding compared to other leading causes of death.
Respiratory Health Association (RHA) is committed to closing this gap and supporting research to explore new and innovative treatments. For many of our researchers, these awards come at a critical point. Our funding can help springboard their research, publish findings and secure additional funding.
We are currently accepting grant applications for funding opportunities to be awarded in 2020!
This year, we are awarding research focused on idiopathic pulmonary fibrosis (IPF) and lung cancer. The awards will support one investigator to build upon an existing IPF or lung cancer portfolio of research or one junior investigator to develop an IPF or Lung Cancer research program.
We are seeking innovative studies into the causes, mechanisms, and treatments of a specific lung disease, including pilot and feasibility studies for disease investigation and development and testing of new methodologies and models. Basic, clinical/translational and social/behavioral studies will be considered, with patient-oriented research being particularly valued.
Timeline for Applications
Full Applications Due
March 9, 2020 by 5 pm (CST)
Anticipated Research Funding Awards Announced
June 1, 2020
Earliest Start Date for Funded Research Projects
July 1, 2020
If you have questions or to learn more about these opportunities, contact Hannah Garza, Program Coordinator at [email protected].